Back to results
US 2021/0261675 A1Published application
Chimeric antigen receptors based on single-domain antibodies and methods of use thereof
AssigneeLegend Biotech USA Inc.
InventorsXiaohu FAN, Chuan-Chu CHOU, Qiuchuan ZHUANG, Pingyan WANG, Lin WANG, Lei YANG, Jiaying HAO
Life of this patent
Estimating the term…
Abstract
The present application provides single-domain antibodies, and chimeric antigen receptors comprising one or more antigen binding domains each comprising a single-domain antibody. Further provided are engineered immune effector cells (such as T cells) comprising the chimeric antigen receptors. Pharmaceutical compositions, kits and methods of treating cancer are also provided.
Claims36
-43. (canceled)
A chimeric antigen receptor (CAR) comprising a polypeptide comprising:
- (a) an extracellular antigen binding domain comprising a first single-domain antibody (sdAb) specifically binding to a first antigen and a second single-domain antibody (sdAb) specifically binding to a second antigen, wherein each of the first and second sdAb is a VHH domain;
- (b) a transmembrane domain;
- and
- (c) an intracellular signaling domain.
1 more element
Dependencies are inferred from the claim text.